


Explore the different ways in which a Texture Analyser can measure the mechanical characteristic of pharmaceutical and medical products.
The measurement of both texture and mechanical properties in pharmaceutical and medical products assumes a critical role driven by the imperative of product stability, consumer acceptance, and safety within the healthcare industry. Achieving these objectives is particularly challenging in the development of new excipients and drug delivery systems, as their effectiveness and cost benefits can be compromised by quality control issues during manufacturing. To address this, manufacturers must rigorously and scientifically assess any potential alterations in product structure and characteristics throughout formulation, processing, and distribution phases. Texture analysis emerges as a pivotal tool, providing reliable and actionable test data pertaining to the physical quality of active ingredients, inactive ingredients, and finished products, including packaging for sterile items, tablets, tablet coatings, gels, and transdermal delivery systems.
In addition, the realms of Tissue Engineering and Regenerative Medicine research heavily rely on the mechanical function of engineered tissues as a primary endpoint for the successful regeneration of biological tissues. Characterising and comparing tissue function to initial benchmark standards are essential steps in establishing quality control criteria for the next generation of healthcare innovations. The scientific measurement of both texture and mechanical properties in pharmaceutical and medical products serves as an indispensable practice that ensures product quality, efficacy, and the advancement of healthcare solutions.
The use of a Texture Analyser in the pharmaceutical and medical industry is crucial for ensuring product efficacy, safety, and regulatory compliance and provides vital insights and advantages:
In summary, the use of a Texture Analyser in the pharmaceutical and medical industry ensures that products and devices are not only safe and effective but also consistent and user-friendly. This rigorous quantification of properties is integral for patient outcomes, regulatory compliance, and the overall reputation of manufacturers in these critical sectors.
The physical properties of pharmaceutical and medical products can significantly impact their performance, stability, and user experience. Here are some of the key texture and mechanical properties that can be measured for pharmaceutical and medical products:
Tablets need to be hard enough to survive transportation without breaking, yet friable enough to disintegrate in the digestive tract. Texture analysers can measure and optimize these parameters.
For medicines encapsulated in soft gels or other materials like films, it's essential to ensure that they neither rupture prematurely nor are too tough to dissolve.
For transdermal patches or adhesive-based drug delivery systems, understanding adhesive strength ensures that the patch stays in place for the required duration but can also be removed without causing harm.
Determining the force required for a needle to penetrate tissues or delivery devices, ensuring patient comfort.
Testing the robustness and durability of protective or functional coatings on pills or medical devices.
Assessing the force needed to depress a syringe plunger, ensuring ease of use.
Relevant for products like adhesive tapes, wound dressings, or certain gel formulations, determining their ability to stretch without breaking or return to their original form after compression.
Relevant for products like medical sponges, powders, granules, pellets or certain implants, evaluating their ability to return to their original shape after compression or remain compressed.
Evaluating how quickly tablets, capsules, or other dosage forms dissolve or disintegrate, which can influence drug release and bioavailability.
The spreadability and consistency of topical gels, ointments, or creams are pivotal for therapeutic efficacy. Texture Analysers can assess these properties, ensuring uniform application and optimal drug delivery.
For injectable drugs, the force required to push the medicine through a syringe (syringeability) is vital for patient comfort and accurate dosing.
Certain drug delivery systems, like hydrogel-based ones, rely on swelling for controlled drug release. A Texture Analyser can measure the rate and extent of this swelling.
For medical stents, understanding their flexibility and resilience under compressive forces.
Although typically tested with dissolution apparatus, Texture Analysers can give insights into how quickly certain drug formulations break down or dissolve.
Measuring the firmness and consistency of pharmaceutical gels or gel-like dosage forms like wound dressings, jelly lubricants, contact lenses, soft gel capsules or suppositories.
For products like medical balloons or certain types of drug delivery systems, this assesses the force or pressure required to cause rupture.
Relevant for products dispensed from tubes, such as certain creams or gels.
For inhalers or powdered medications, consistent flowability is critical for accurate dosing.
By understanding and optimising these properties, pharmaceutical companies and medical device manufacturers can ensure that their products are effective, safe, and user-friendly. Texture Analysers provide the quantitative data needed to make informed decisions during the product development process.
Whether its providing the solution for Reckitt Benkiser to measure their alginate raft strength, a means of characterising Allergan Pharmaceuticals soft gelatin capsule dosage form or offering a method for Aprecia Pharmaceuticals to measure tablet dispersion properties, a Texture Analyser is adaptable and flexible in its application to measure the bespoke mechanical properties of your product and then enable its quality to be controlled in your manufacturing to guarantee consistency and customer satisfaction.
With deep expertise in pharmaceutical and medical product mechanical analysis, we’re well equipped to support innovation in this sector – just ask our customers.
A wide range of probes and attachments an be integrated with our instruments, allowing testing to be precisely adapted to the material or product under evaluation. Applications include compression tests to compare tablet hardness and failure properties, burst tests to assess capsule rupture force or adhesion testing to measure mucoadhesive/bioadhesion properties.
As the pharmaceutical industry innovates, so our materials analysis evolves, developing and adapting to provide new test solutions and methodologies for highly specific requirements. When a suitable solution did not already exist, we developed one – examples include the Tablet Disintegration Rig, Capsule/Loop Tensile Rig, and Granule Compaction Rig, all of which are part of our growing portfolio of Community Registered Designs.
The examples provided illustrate a selection of specialised attachments and commonly performed measurements within this application area. This list is not exhaustive; a wide range of additional options are available for the testing of pharmaceutical and medical products. All instruments in the Texture Analyser range can be used to perform the tests described.
Exponent Connect software includes a comprehensive range of test methods for pharmaceutical and medical products, all instantly accessible at the click of a button. We streamline your texture testing process, ensuring faster access to methods and ready-to-use analysis files for your product properties.
Pharmaceuticals and medical products are ever-evolving sectors with continuous research to improve efficacy, delivery mechanisms, and patient outcomes. Here are some of the newer ingredient and product ideas in pharmaceutical and medical research, development, and production and a typical academic reference to show how the Texture Analyser has already being applied:
Custom-tailored treatments for individual patients based on their genetic makeup or unique response profiles, ensuring maximum efficacy and minimal side effects.
Devices or implants made from materials designed to break down over time in the body, reducing the need for follow-up surgeries for removal.
Using nanoparticles for targeted drug delivery, improving the precision and effectiveness of treatments.
Treatments that involve altering the genes inside a patient's cells to treat or prevent disease.
Devices like glucose monitors and heart rate trackers that patients can wear to monitor various health metrics continuously.
Proteins, monoclonal antibodies, or nucleic acids used to treat diseases. Examples include drugs for autoimmune diseases and certain types of cancer.
Leveraging the body's immune system to target and destroy disease, especially in cancer treatment.
Inactive compounds that become active drugs when metabolised in the body, allowing for targeted delivery or improved drug properties.
Stents or patches that slowly release drugs over time to a targeted area.
Drugs developed specifically for rare diseases.
Products that use technologies like negative pressure or hydrogels to promote wound healing.
Biologically derived drugs that are "similar" to another already FDA-approved biological product. They can provide more affordable treatment options once the original product's patents expire.
Utilising 3D printing technology to create patient-specific pills or medical devices.
Pills embedded with digestible sensors to monitor drug intake, ensuring patients adhere to their medication regimens.
Drugs designed to be released over a prolonged period, reducing the frequency of doses needed.
Drugs or treatments designed to target or utilise the body's microbiome (the collection of microbes living in and on our bodies) to promote health and treat diseases.
Utilising RNA molecules, such as siRNA or mRNA, to treat diseases. mRNA vaccines for COVID-19 are a notable example.
Short chains of amino acids that can act as hormones, neurotransmitters, or growth factors.
Designing and constructing novel biological entities or redesigning existing biological systems.
Software-based therapies, sometimes paired with drugs, to treat diseases.
Devices interfacing with the brain or nervous system, including neuroprosthetics or brain-computer interfaces.
As with all healthcare-related topics, the integration of these trends and innovations into the industry involves rigorous testing, regulatory scrutiny, and continuous monitoring for safety and efficacy. The aforementioned innovations provide a glimpse into the future of medicine and the direction in which medical care is heading.
Here is some recent interesting research in pharmaceutical and medical product development using the Texture Analyser: